Literature DB >> 21036397

Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.

Luca Malcovati1, Régis Peffault de Latour, Antonio Risitano.   

Abstract

Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21036397     DOI: 10.1016/j.leukres.2010.10.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  1 in total

1.  Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.

Authors:  Hui-zhen Du; Qian Wang; Jian Ji; Bao-ming Shen; Shao-chun Wei; Li-juan Liu; Juan Ding; Dao-xin Ma; Wen Wang; Jun Peng; Ming Hou
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.